Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Account Payables: 2021-2025

Historic Change in Account Payables for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$1.2 million.

  • Core Scientific's Change in Account Payables fell 674.38% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year decrease of 124.50%. This contributed to the annual value of -$12.3 million for FY2024, which is 110.32% down from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Change in Account Payables is -$1.2 million, which was up 40.55% from -$2.1 million recorded in Q2 2025.
  • Core Scientific's 5-year Change in Account Payables high stood at $86.1 million for Q4 2023, and its period low was -$39.0 million during Q3 2021.
  • Over the past 3 years, Core Scientific's median Change in Account Payables value was -$632,000 (recorded in 2024), while the average stood at $8.1 million.
  • As far as peak fluctuations go, Core Scientific's Change in Account Payables soared by 870.21% in 2023, and later tumbled by 674.38% in 2025.
  • Core Scientific's Change in Account Payables (Quarterly) stood at $13.1 million in 2021, then soared by 80.80% to $23.8 million in 2022, then skyrocketed by 262.56% to $86.1 million in 2023, then tumbled by 100.73% to -$632,000 in 2024, then slumped by 674.38% to -$1.2 million in 2025.
  • Its Change in Account Payables was -$1.2 million in Q3 2025, compared to -$2.1 million in Q2 2025 and -$14.3 million in Q1 2025.